PDB Short entry for 5IU2 HEADER TRANSFERASE 17-MAR-16 5IU2 TITLE DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT, SELECTIVE TITLE 2 AND IN VIVO EFFICACIOUS COT KINASE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CANCER OSAKA THYROID ONCOGENE,PROTO-ONCOGENE C-COT, COMPND 5 SERINE/THREONINE-PROTEIN KINASE COT,TUMOR PROGRESSION LOCUS 2,TPL-2; COMPND 6 EC: 2.7.11.25 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS COT, TPL-2, MAP3K8, KINASE, INHIBITOR, COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.GUTMANN,A.HINNIGER REVDAT 3 07-FEB-24 5IU2 1 REMARK REVDAT 2 07-SEP-16 5IU2 1 JRNL REVDAT 1 24-AUG-16 5IU2 0 SPRSDE 24-AUG-16 5IU2 4Y83 4Y85 JRNL AUTH R.GLATTHAR,A.STOJANOVIC,T.TROXLER,H.MATTES,H.MOBITZ, JRNL AUTH 2 R.BEERLI,J.BLANZ,E.GASSMANN,P.DRUCKES,G.FENDRICH,S.GUTMANN, JRNL AUTH 3 G.MARTINY-BARON,F.SPENCE,J.HORNFELD,J.E.PEEL,H.SPARRER JRNL TITL DISCOVERY OF IMIDAZOQUINOLINES AS A NOVEL CLASS OF POTENT, JRNL TITL 2 SELECTIVE, AND IN VIVO EFFICACIOUS CANCER OSAKA THYROID JRNL TITL 3 (COT) KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 59 7544 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27502541 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00598 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.234 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1019 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2936 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2998 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2789 REMARK 3 BIN R VALUE (WORKING SET) : 0.2965 REMARK 3 BIN FREE R VALUE : 0.3598 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 147 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4769 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.06000 REMARK 3 B22 (A**2) : 1.22620 REMARK 3 B33 (A**2) : 2.83380 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.429 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.344 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.344 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.890 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.851 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4980 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6784 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1625 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 92 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 728 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4980 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 655 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5642 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.37 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.99 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -14.4225 17.2603 -6.6568 REMARK 3 T TENSOR REMARK 3 T11: -0.1306 T22: -0.0750 REMARK 3 T33: -0.0317 T12: -0.0144 REMARK 3 T13: 0.0275 T23: 0.0734 REMARK 3 L TENSOR REMARK 3 L11: 0.4391 L22: 1.4279 REMARK 3 L33: 0.3266 L12: -0.1672 REMARK 3 L13: 0.0258 L23: 0.3918 REMARK 3 S TENSOR REMARK 3 S11: 0.0293 S12: -0.0612 S13: 0.0302 REMARK 3 S21: -0.1315 S22: -0.0004 S23: -0.1273 REMARK 3 S31: -0.0601 S32: -0.0454 S33: -0.0289 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -43.4190 0.6358 -18.5099 REMARK 3 T TENSOR REMARK 3 T11: -0.1716 T22: -0.0309 REMARK 3 T33: -0.0602 T12: 0.0241 REMARK 3 T13: -0.0018 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 0.2032 L22: 0.1924 REMARK 3 L33: 0.9980 L12: 0.0091 REMARK 3 L13: -0.0428 L23: 0.4532 REMARK 3 S TENSOR REMARK 3 S11: -0.0051 S12: 0.1091 S13: 0.0430 REMARK 3 S21: -0.0593 S22: -0.0596 S23: 0.0313 REMARK 3 S31: -0.0963 S32: -0.0758 S33: 0.0647 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IU2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219427. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20386 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 71.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.530 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49200 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4Y85 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 7, 1.7 M AMMONIUM REMARK 280 SULFATE, 0.01 M PROLINE. PROTEIN SOLUTION (COT:COMPOUND 1:1) WAS REMARK 280 MIXED WITH AN EQUAL VOLUME (1 UL) OF RESERVOIR SOLUTION. REMARK 280 EQUILIBRATION WAS DONE OVER 500 UL RESERVOIR SOLUTION., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.56000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 62.56000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 64 REMARK 465 PRO A 65 REMARK 465 SER A 66 REMARK 465 GLY A 67 REMARK 465 GLN A 68 REMARK 465 GLU A 69 REMARK 465 VAL A 70 REMARK 465 PRO A 71 REMARK 465 TRP A 72 REMARK 465 THR A 94 REMARK 465 ALA A 95 REMARK 465 LYS A 96 REMARK 465 HIS A 97 REMARK 465 ILE A 139 REMARK 465 PRO A 390 REMARK 465 PRO A 391 REMARK 465 ARG A 392 REMARK 465 GLU A 393 REMARK 465 ASP A 394 REMARK 465 GLN A 395 REMARK 465 GLY B 64 REMARK 465 PRO B 65 REMARK 465 SER B 66 REMARK 465 GLY B 67 REMARK 465 GLN B 68 REMARK 465 GLU B 69 REMARK 465 VAL B 70 REMARK 465 PRO B 71 REMARK 465 TRP B 72 REMARK 465 THR B 94 REMARK 465 ALA B 95 REMARK 465 LYS B 96 REMARK 465 ILE B 139 REMARK 465 PRO B 390 REMARK 465 PRO B 391 REMARK 465 ARG B 392 REMARK 465 GLU B 393 REMARK 465 ASP B 394 REMARK 465 GLN B 395 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 73 CG CD1 CD2 REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 ASN A 89 CG OD1 ND2 REMARK 470 PHE A 98 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 101 CG CD OE1 NE2 REMARK 470 ARG A 102 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 104 CG CD OE1 NE2 REMARK 470 SER A 125 OG REMARK 470 SER A 141 OG REMARK 470 ASP A 142 CG OD1 OD2 REMARK 470 LYS A 151 CG CD CE NZ REMARK 470 LYS A 159 CG CD CE NZ REMARK 470 LYS A 175 CG CD CE NZ REMARK 470 PRO A 176 CG CD REMARK 470 GLU A 201 CG CD OE1 OE2 REMARK 470 LYS A 248 CD CE NZ REMARK 470 SER A 263 OG REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 ASP A 286 CG OD1 OD2 REMARK 470 ARG A 288 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 302 CD NE CZ NH1 NH2 REMARK 470 THR A 322 CG2 REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 ASP A 352 CG OD1 OD2 REMARK 470 ASP A 355 CG OD1 OD2 REMARK 470 ASP A 356 CG OD1 OD2 REMARK 470 LYS A 384 CG CD CE NZ REMARK 470 GLU A 386 CG CD OE1 OE2 REMARK 470 LEU B 73 CG CD1 CD2 REMARK 470 ARG B 77 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 SER B 92 OG REMARK 470 ASN B 93 CG OD1 ND2 REMARK 470 HIS B 97 CG ND1 CD2 CE1 NE2 REMARK 470 PHE B 98 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 101 CG CD OE1 NE2 REMARK 470 ARG B 102 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 104 CG CD OE1 NE2 REMARK 470 SER B 125 OG REMARK 470 LYS B 133 CG CD CE NZ REMARK 470 SER B 141 OG REMARK 470 ASP B 142 CG OD1 OD2 REMARK 470 ILE B 144 CG1 CG2 CD1 REMARK 470 LYS B 151 CG CD CE NZ REMARK 470 LYS B 159 CG CD CE NZ REMARK 470 LYS B 175 CG CD CE NZ REMARK 470 PRO B 176 CG CD REMARK 470 ARG B 186 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 201 CG CD OE1 OE2 REMARK 470 LYS B 248 CD CE NZ REMARK 470 SER B 263 OG REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 ARG B 288 NE CZ NH1 NH2 REMARK 470 ARG B 302 CG CD NE CZ NH1 NH2 REMARK 470 THR B 322 CG2 REMARK 470 LYS B 345 CG CD CE NZ REMARK 470 ASP B 355 CG OD1 OD2 REMARK 470 ASP B 356 CG OD1 OD2 REMARK 470 GLU B 363 CG CD OE1 OE2 REMARK 470 GLU B 386 CG CD OE1 OE2 REMARK 470 ASN B 389 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 252 -5.73 71.95 REMARK 500 ASP A 253 57.06 -143.74 REMARK 500 ASP A 270 91.75 58.81 REMARK 500 SER A 338 39.18 -144.07 REMARK 500 ASP A 356 66.80 -103.31 REMARK 500 HIS B 252 -5.78 71.78 REMARK 500 ASP B 253 56.94 -143.61 REMARK 500 ASP B 270 91.68 58.50 REMARK 500 SER B 338 39.75 -143.31 REMARK 500 ASP B 356 65.98 -101.88 REMARK 500 GLU B 370 123.54 -39.30 REMARK 500 LEU B 388 51.38 -96.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS B 175 -10.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6DA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6DA B 401 DBREF 5IU2 A 66 395 UNP P41279 M3K8_HUMAN 66 395 DBREF 5IU2 B 66 395 UNP P41279 M3K8_HUMAN 66 395 SEQADV 5IU2 GLY A 64 UNP P41279 EXPRESSION TAG SEQADV 5IU2 PRO A 65 UNP P41279 EXPRESSION TAG SEQADV 5IU2 GLY B 64 UNP P41279 EXPRESSION TAG SEQADV 5IU2 PRO B 65 UNP P41279 EXPRESSION TAG SEQRES 1 A 332 GLY PRO SER GLY GLN GLU VAL PRO TRP LEU SER SER VAL SEQRES 2 A 332 ARG TYR GLY THR VAL GLU ASP LEU LEU ALA PHE ALA ASN SEQRES 3 A 332 HIS ILE SER ASN THR ALA LYS HIS PHE TYR GLY GLN ARG SEQRES 4 A 332 PRO GLN GLU SER GLY ILE LEU LEU ASN MET VAL ILE THR SEQRES 5 A 332 PRO GLN ASN GLY ARG TYR GLN ILE ASP SER ASP VAL LEU SEQRES 6 A 332 LEU ILE PRO TRP LYS LEU THR TYR ARG ASN ILE GLY SER SEQRES 7 A 332 ASP PHE ILE PRO ARG GLY ALA PHE GLY LYS VAL TYR LEU SEQRES 8 A 332 ALA GLN ASP ILE LYS THR LYS LYS ARG MET ALA CYS LYS SEQRES 9 A 332 LEU ILE PRO VAL ASP GLN PHE LYS PRO SER ASP VAL GLU SEQRES 10 A 332 ILE GLN ALA CYS PHE ARG HIS GLU ASN ILE ALA GLU LEU SEQRES 11 A 332 TYR GLY ALA VAL LEU TRP GLY GLU THR VAL HIS LEU PHE SEQRES 12 A 332 MET GLU ALA GLY GLU GLY GLY SER VAL LEU GLU LYS LEU SEQRES 13 A 332 GLU SER CYS GLY PRO MET ARG GLU PHE GLU ILE ILE TRP SEQRES 14 A 332 VAL THR LYS HIS VAL LEU LYS GLY LEU ASP PHE LEU HIS SEQRES 15 A 332 SER LYS LYS VAL ILE HIS HIS ASP ILE LYS PRO SER ASN SEQRES 16 A 332 ILE VAL PHE MET SER THR LYS ALA VAL LEU VAL ASP PHE SEQRES 17 A 332 GLY LEU SER VAL GLN MET THR GLU ASP VAL TYR PHE PRO SEQRES 18 A 332 LYS ASP LEU ARG GLY THR GLU ILE TYR MET SER PRO GLU SEQRES 19 A 332 VAL ILE LEU CYS ARG GLY HIS SER THR LYS ALA ASP ILE SEQRES 20 A 332 TYR SER LEU GLY ALA THR LEU ILE HIS MET GLN THR GLY SEQRES 21 A 332 THR PRO PRO TRP VAL LYS ARG TYR PRO ARG SER ALA TYR SEQRES 22 A 332 PRO SER TYR LEU TYR ILE ILE HIS LYS GLN ALA PRO PRO SEQRES 23 A 332 LEU GLU ASP ILE ALA ASP ASP CYS SER PRO GLY MET ARG SEQRES 24 A 332 GLU LEU ILE GLU ALA SER LEU GLU ARG ASN PRO ASN HIS SEQRES 25 A 332 ARG PRO ARG ALA ALA ASP LEU LEU LYS HIS GLU ALA LEU SEQRES 26 A 332 ASN PRO PRO ARG GLU ASP GLN SEQRES 1 B 332 GLY PRO SER GLY GLN GLU VAL PRO TRP LEU SER SER VAL SEQRES 2 B 332 ARG TYR GLY THR VAL GLU ASP LEU LEU ALA PHE ALA ASN SEQRES 3 B 332 HIS ILE SER ASN THR ALA LYS HIS PHE TYR GLY GLN ARG SEQRES 4 B 332 PRO GLN GLU SER GLY ILE LEU LEU ASN MET VAL ILE THR SEQRES 5 B 332 PRO GLN ASN GLY ARG TYR GLN ILE ASP SER ASP VAL LEU SEQRES 6 B 332 LEU ILE PRO TRP LYS LEU THR TYR ARG ASN ILE GLY SER SEQRES 7 B 332 ASP PHE ILE PRO ARG GLY ALA PHE GLY LYS VAL TYR LEU SEQRES 8 B 332 ALA GLN ASP ILE LYS THR LYS LYS ARG MET ALA CYS LYS SEQRES 9 B 332 LEU ILE PRO VAL ASP GLN PHE LYS PRO SER ASP VAL GLU SEQRES 10 B 332 ILE GLN ALA CYS PHE ARG HIS GLU ASN ILE ALA GLU LEU SEQRES 11 B 332 TYR GLY ALA VAL LEU TRP GLY GLU THR VAL HIS LEU PHE SEQRES 12 B 332 MET GLU ALA GLY GLU GLY GLY SER VAL LEU GLU LYS LEU SEQRES 13 B 332 GLU SER CYS GLY PRO MET ARG GLU PHE GLU ILE ILE TRP SEQRES 14 B 332 VAL THR LYS HIS VAL LEU LYS GLY LEU ASP PHE LEU HIS SEQRES 15 B 332 SER LYS LYS VAL ILE HIS HIS ASP ILE LYS PRO SER ASN SEQRES 16 B 332 ILE VAL PHE MET SER THR LYS ALA VAL LEU VAL ASP PHE SEQRES 17 B 332 GLY LEU SER VAL GLN MET THR GLU ASP VAL TYR PHE PRO SEQRES 18 B 332 LYS ASP LEU ARG GLY THR GLU ILE TYR MET SER PRO GLU SEQRES 19 B 332 VAL ILE LEU CYS ARG GLY HIS SER THR LYS ALA ASP ILE SEQRES 20 B 332 TYR SER LEU GLY ALA THR LEU ILE HIS MET GLN THR GLY SEQRES 21 B 332 THR PRO PRO TRP VAL LYS ARG TYR PRO ARG SER ALA TYR SEQRES 22 B 332 PRO SER TYR LEU TYR ILE ILE HIS LYS GLN ALA PRO PRO SEQRES 23 B 332 LEU GLU ASP ILE ALA ASP ASP CYS SER PRO GLY MET ARG SEQRES 24 B 332 GLU LEU ILE GLU ALA SER LEU GLU ARG ASN PRO ASN HIS SEQRES 25 B 332 ARG PRO ARG ALA ALA ASP LEU LEU LYS HIS GLU ALA LEU SEQRES 26 B 332 ASN PRO PRO ARG GLU ASP GLN HET 6DA A 401 37 HET 6DA B 401 37 HETNAM 6DA N-[2-(MORPHOLIN-4-YL)ETHYL]-6-(8-PHENYL-1H-IMIDAZO[4,5- HETNAM 2 6DA C][1,7]NAPHTHYRIDIN-1-YL)-1,3-BENZOTHIAZOL-2-AMINE FORMUL 3 6DA 2(C28 H25 N7 O S) FORMUL 5 HOH *150(H2 O) HELIX 1 AA1 THR A 80 SER A 92 1 13 HELIX 2 AA2 GLN A 122 ASP A 126 1 5 HELIX 3 AA3 PRO A 176 PHE A 185 1 10 HELIX 4 AA4 SER A 214 GLY A 223 1 10 HELIX 5 AA5 ARG A 226 LYS A 247 1 22 HELIX 6 AA6 LYS A 255 SER A 257 5 3 HELIX 7 AA7 THR A 290 MET A 294 5 5 HELIX 8 AA8 SER A 295 CYS A 301 1 7 HELIX 9 AA9 THR A 306 GLY A 323 1 18 HELIX 10 AB1 SER A 338 ALA A 347 1 10 HELIX 11 AB2 SER A 358 LEU A 369 1 12 HELIX 12 AB3 ASN A 372 ARG A 376 5 5 HELIX 13 AB4 ARG A 378 LYS A 384 1 7 HELIX 14 AB5 THR B 80 SER B 92 1 13 HELIX 15 AB6 GLN B 122 ASP B 126 1 5 HELIX 16 AB7 PRO B 176 PHE B 185 1 10 HELIX 17 AB8 SER B 214 GLY B 223 1 10 HELIX 18 AB9 ARG B 226 LYS B 247 1 22 HELIX 19 AC1 LYS B 255 SER B 257 5 3 HELIX 20 AC2 THR B 290 MET B 294 5 5 HELIX 21 AC3 SER B 295 CYS B 301 1 7 HELIX 22 AC4 THR B 306 GLY B 323 1 18 HELIX 23 AC5 SER B 338 ALA B 347 1 10 HELIX 24 AC6 SER B 358 LEU B 369 1 12 HELIX 25 AC7 ASN B 372 ARG B 376 5 5 HELIX 26 AC8 ARG B 378 LYS B 384 1 7 SHEET 1 AA1 7 VAL A 76 TYR A 78 0 SHEET 2 AA1 7 GLU A 105 LEU A 109 1 O GLY A 107 N ARG A 77 SHEET 3 AA1 7 LEU A 193 TRP A 199 -1 O LEU A 198 N SER A 106 SHEET 4 AA1 7 THR A 202 MET A 207 -1 O HIS A 204 N VAL A 197 SHEET 5 AA1 7 ARG A 163 PRO A 170 -1 N ILE A 169 O VAL A 203 SHEET 6 AA1 7 LYS A 151 ASP A 157 -1 N LYS A 151 O LEU A 168 SHEET 7 AA1 7 VAL A 127 PRO A 131 -1 N ILE A 130 O LEU A 154 SHEET 1 AA2 2 VAL A 249 ILE A 250 0 SHEET 2 AA2 2 VAL A 275 GLN A 276 -1 O VAL A 275 N ILE A 250 SHEET 1 AA3 2 ILE A 259 PHE A 261 0 SHEET 2 AA3 2 ALA A 266 LEU A 268 -1 O VAL A 267 N VAL A 260 SHEET 1 AA4 7 VAL B 76 TYR B 78 0 SHEET 2 AA4 7 GLU B 105 LEU B 109 1 O GLY B 107 N ARG B 77 SHEET 3 AA4 7 LEU B 193 TRP B 199 -1 O LEU B 198 N SER B 106 SHEET 4 AA4 7 THR B 202 MET B 207 -1 O HIS B 204 N VAL B 197 SHEET 5 AA4 7 ARG B 163 PRO B 170 -1 N ILE B 169 O VAL B 203 SHEET 6 AA4 7 LYS B 151 ASP B 157 -1 N TYR B 153 O CYS B 166 SHEET 7 AA4 7 VAL B 127 PRO B 131 -1 N ILE B 130 O LEU B 154 SHEET 1 AA5 2 VAL B 249 ILE B 250 0 SHEET 2 AA5 2 VAL B 275 GLN B 276 -1 O VAL B 275 N ILE B 250 SHEET 1 AA6 2 ILE B 259 PHE B 261 0 SHEET 2 AA6 2 ALA B 266 LEU B 268 -1 O VAL B 267 N VAL B 260 CISPEP 1 ALA A 347 PRO A 348 0 5.93 CISPEP 2 ALA B 347 PRO B 348 0 2.44 SITE 1 AC1 22 TRP A 132 LEU A 134 PHE A 149 GLY A 150 SITE 2 AC1 22 VAL A 152 ALA A 165 LYS A 167 MET A 207 SITE 3 AC1 22 GLU A 208 GLY A 210 GLY A 213 SER A 214 SITE 4 AC1 22 GLU A 217 SER A 257 ASN A 258 VAL A 260 SITE 5 AC1 22 VAL A 269 ASP A 270 HOH A 502 HOH A 539 SITE 6 AC1 22 HOH A 542 HOH A 556 SITE 1 AC2 22 TRP B 132 LEU B 134 PHE B 149 GLY B 150 SITE 2 AC2 22 VAL B 152 ALA B 165 LYS B 167 MET B 207 SITE 3 AC2 22 GLU B 208 ALA B 209 GLY B 210 GLY B 213 SITE 4 AC2 22 SER B 214 GLU B 217 SER B 257 ASN B 258 SITE 5 AC2 22 VAL B 260 VAL B 269 ASP B 270 HOH B 506 SITE 6 AC2 22 HOH B 508 HOH B 534 CRYST1 65.480 87.430 125.120 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015272 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011438 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007992 0.00000